HR 2232
108th Congress
House
Health
Commerce
Consumer education
Drug industry
Drugs
Government Operations and Politics
Government paperwork
Pharmacies
Wholesale trade
To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 2, 2003
Referred to the Subcommittee on Health.
May 22, 2003
Referred to the House Committee on Energy and Commerce.
May 22, 2003
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Amends the Federal Food, Drug, and Cosmetic Act to require the wholesale distributor of certain drugs who is not the manufacturer or an authorized distributor of record for a calendar year of a drug to provide to the recipient of the drug a statement identifying each prior sale, purchase, or trade of such drug (currently, the language "for a calendar year" is not in the Act).
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cosponsors
4
Cite this page
U.S. Congress. (2026). H.R. 2232: To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.. 108th Congress. Open America. https://openamerica.io/bill/108-HR-2232/
"H.R. 2232: To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-2232/.
H.R. 2232, 108th Cong. (2026), https://openamerica.io/bill/108-HR-2232/.
[H.R. 2232: To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.](https://openamerica.io/bill/108-HR-2232/)